Sign inGet started

Harris Geoffrey E.

Insider CIK 1611395 · ANCI Director · CGIX Director · NONE Director · CNSO Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VYNT Vyant Bio, Inc. A Award2023-01-172023-01-195,712— $019,761SEC↗
VYNT Vyant Bio, Inc. S Sale2022-11-182022-11-2299$1.34 $13314,685SEC↗
VYNT Vyant Bio, Inc. S Sale2022-11-182022-11-22666$1.33 $88614,019SEC↗
VYNT Vyant Bio, Inc. A Award2022-10-172022-10-1910,841— $073,920SEC↗
VYNT Vyant Bio, Inc. A Award2022-07-182022-07-296,141— $063,079SEC↗
VYNT Vyant Bio, Inc. A Award2022-04-182022-04-195,157— $056,938SEC↗
VYNT Vyant Bio, Inc. A Award2022-03-302022-04-0143,478— $051,781SEC↗
VYNT Vyant Bio, Inc. A Award2022-01-182022-01-204,055$1.31 $5.3K8,303SEC↗
VYNT Vyant Bio, Inc. A Award deriv2021-03-302021-04-0113,015— $013,015SEC↗
CGIX CANCER GENETICS, INC A Award deriv2019-07-232019-08-19100,000— $0100,000SEC↗
NONE Telemynd, Inc. J Other2019-07-162019-07-1897,110— $097,110SEC↗
CGIX CANCER GENETICS, INC P Buy2019-01-142019-01-16100,000$0.23 $23.0K127,500SEC↗
MYND MYnd Analytics, Inc. A Award2018-10-082018-10-1045,000$1.38 $62.1K97,110SEC↗
MYND MYnd Analytics, Inc. P Buy2017-12-062017-12-071,000$3.85 $3.9K48,610SEC↗
MYND MYnd Analytics, Inc. P Buy2017-12-062017-12-073,500$3.80 $13.3K52,110SEC↗
MYND MYnd Analytics, Inc. P Buy2017-12-052017-12-0752$3.60 $18747,610SEC↗
CGIX CANCER GENETICS, INC A Award deriv2017-09-282017-10-025,000— $05,000SEC↗
CGIX CANCER GENETICS, INC A Award2017-09-282017-10-022,500— $027,500SEC↗
MYND MYnd Analytics, Inc. A Award deriv2017-09-192017-09-2118,000— $018,000SEC↗
MYND MYnd Analytics, Inc. A Award2017-09-192017-09-2118,000— $047,558SEC↗
CGIX CANCER GENETICS, INC A Award deriv2017-06-072017-06-0810,000— $010,000SEC↗
CGIX CANCER GENETICS, INC A Award2017-06-072017-06-082,500— $025,000SEC↗
CGIX CANCER GENETICS, INC P Buy2017-05-162017-05-162,500$3.75 $9.4K22,500SEC↗
MYAN MYnd Analytics, Inc. A Award2017-03-032017-03-035,000$6.25 $31.3K29,558SEC↗
CGIX CANCER GENETICS, INC P Buy2016-12-142016-12-142,500$1.50 $3.8K20,000SEC↗
CGIX CANCER GENETICS, INC P Buy2016-11-142016-11-165,000$1.55 $7.8K17,500SEC↗
MYAN MYnd Analytics, Inc. A Award2016-11-012016-11-0220,000— $024,558SEC↗
CGIX CANCER GENETICS, INC A Award deriv2016-10-112016-10-1310,000— $010,000SEC↗
CGIX CANCER GENETICS, INC A Award2016-10-112016-10-132,500— $012,500SEC↗
CNSO MYnd Analytics, Inc. M Exercise deriv2016-09-212016-09-230— $00SEC↗
CNSO MYnd Analytics, Inc. D To issuer deriv2016-09-212016-09-230— $00SEC↗
CNSO MYnd Analytics, Inc. M Exercise2016-09-212016-09-232,058$5.00 $10.3K4,558SEC↗
CNSO MYnd Analytics, Inc. A Award2016-04-052016-04-07500,000— $0500,000SEC↗
CNSO MYnd Analytics, Inc. A Award deriv2016-02-232016-02-25200,000— $0200,000SEC↗
CNSO MYnd Analytics, Inc. A Award deriv2016-02-232016-02-250— $00SEC↗
ANCI American CareSource Holdin A Award2015-08-282015-09-0110,000— $020,000SEC↗
CNSO CNS RESPONSE, INC. A Award deriv2015-08-202015-08-24250,000— $0250,000SEC↗
CGIX CANCER GENETICS, INC A Award deriv2015-05-142015-05-1810,000— $010,000SEC↗
CGIX CANCER GENETICS, INC P Buy2015-05-142015-05-185,000$10.79 $53.9K5,000SEC↗
CGIX CANCER GENETICS, INC A Award2015-05-142015-05-185,000— $010,000SEC↗
CGIX CANCER GENETICS, INC A Award deriv2014-12-112014-12-155,000— $05,000SEC↗
ANCI American Caresource Holdin A Award2014-06-242014-06-2610,000— $010,000SEC↗